TRPV1 and pulmonary arterial hypertension: Because pretreatment with capsaicin, a specific activator of TRPV1, has been reported to alleviate PAH inflammation via depletion of proinflammatory neuropeptides in advance, and the p38 mitogen-activated protein kinase (MAPK) signaling pathway may participate in this process [45].